KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Long-Term Deferred Tax: 2010-2025

Historic Long-Term Deferred Tax for Biomarin Pharmaceutical (BMRN) over the last 15 years, with Sep 2025 value amounting to $1.5 billion.

  • Biomarin Pharmaceutical's Long-Term Deferred Tax fell 1.42% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 1.42%. This contributed to the annual value of $1.5 billion for FY2024, which is 3.65% down from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Long-Term Deferred Tax is $1.5 billion, which was up 5.75% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Long-Term Deferred Tax registered a high of $1.5 billion during Q1 2024, and its lowest value of $1.4 billion during Q2 2025.
  • In the last 3 years, Biomarin Pharmaceutical's Long-Term Deferred Tax had a median value of $1.5 billion in 2023 and averaged $1.5 billion.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Long-Term Deferred Tax soared by 164.71% in 2021, and later fell by 7.64% in 2025.
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Long-Term Deferred Tax stood at $1.5 billion in 2021, then climbed by 3.81% to $1.5 billion in 2022, then increased by 2.68% to $1.5 billion in 2023, then fell by 3.65% to $1.5 billion in 2024, then declined by 1.42% to $1.5 billion in 2025.
  • Its Long-Term Deferred Tax was $1.5 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.5 billion in Q1 2025.